Go Pro
→ If you keep cash in a U.S. bank account… read this NOW (From Banyan Hill Publishing) (Ad)tc pixel
LON:HLN

Haleon Interim Earnings Report

Haleon logo
GBX 342.70 -2.20 (-0.64%)
As of 09/25/2026 12:05 PM Eastern
ProfileEarnings HistoryForecast

Haleon EPS Results

Actual EPS
GBX 8.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Haleon Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Haleon Announcement Details

Quarter
Interim
Date
7/31/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Haleon Earnings Headlines

Haleon Turns to Weight-Loss Drug Users for its Next U.S. Growth Opportunity
September 21, 2026  |  insidermonkey.comhttps://www.insidermonkey.com/news/haleon-turns-to-weight-loss-drug-users-for-its-next-u-s-growth-opportunity-1841720/
Haleon is gaining from the side effects of weight-loss drugs
September 18, 2026  |  msn.comhttps://www.msn.com/en-us/news/money/haleon-is-gaining-from-the-side-effects-of-weight-loss-drugs/ar-AA2cxjUA
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to trigger the next crash. The research firm Bernstein Research said this AI company has the power to crash the global economy for a decade, the CEO just issued a CODE RED in an internal memo warning employees they're dealing with a critical situation, and another company executive even implied they might need a government bailout. The last time I saw something like this was in 2008 when I predicted a stock market meltdown just three weeks before Lehman went under.tc pixel
 |  Paradigm Press (Ad)
Haleon Discloses Director Share Purchase via Dividend Reinvestment
September 18, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/haleon-discloses-director-share-purchase-via-dividend-reinvestment?utm_source=marketbeat.com&utm_medium=referral
Advil-maker Haleon boosts US sales by targeting consumers on weight-loss drugs
September 16, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/advil-maker-haleon-boosts-us-sales-by-targeting-consumers-on-weight-loss-drugs/ar-AA2clx7e
Deutsche Bank Reaffirms Their Sell Rating on Haleon PLC (HLN)
September 10, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/HLN/pressreleases/4536460/deutsche-bank-reaffirms-their-sell-rating-on-haleon-plc-hln/
See More Haleon Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Haleon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Haleon and other key companies, straight to your email.

About Haleon

Haleon (LON:HLN) (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.

View Haleon Profile
Earnings Tools